Assignee
REDX PHARMA PLC
GB·14 granted patents·9 pending applications·67 citations·filing 2014–2023
Top patents by PatentIndex Score
23 records- 0192US10183939B2Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancersREDX PHARMA PLC·Filed 2015·Granted Jan 22, 2019·42 cites·21 claims
- 0289US11878020B2Modulators of Rho-associated protein kinaseREDX PHARMA PLC·Filed 2022·Granted Jan 23, 2024·1 cites·20 claims
- 0389US10047079B2N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathwayREDX PHARMA PLC·Filed 2015·Granted Aug 14, 2018·6 cites·16 claims
- 0487US10793560B2N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathwayREDX PHARMA PLC·Filed 2018·Granted Oct 6, 2020·3 cites·17 claims
- 0585US10202375B2N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitorsREDX PHARMA PLC·Filed 2015·Granted Feb 12, 2019·5 cites·24 claims
- 0684US11497751B2Modulators of Rho-associated protein kinaseREDX PHARMA PLC·Filed 2019·Granted Nov 15, 2022·5 cites·25 claims
- 0783US11643408B2N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathwayREDX PHARMA PLC·Filed 2020·Granted May 9, 2023·1 cites·18 claims
- 0881US12202826B2N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathwayREDX PHARMA PLC·Filed 2023·Granted Jan 21, 2025·0 cites·10 claims
- 0975US10793562B2N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitorsREDX PHARMA PLC·Filed 2019·Granted Oct 6, 2020·1 cites·35 claims
- 1075US2023121489A1N-pyridinyl acetamide derivatives as wnt signalling pathway inhibitorsREDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 1172US9579319B2Heterocyclic compounds as hedgehog signaling pathway inhibitorsREDX PHARMA PLC·Filed 2014·Granted Feb 28, 2017·1 cites·37 claims
- 1271US11459326B2N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitorsREDX PHARMA PLC·Filed 2020·Granted Oct 4, 2022·0 cites·4 claims
- 1371US9850234B2Pyridine derivatives as soft rock inhibitorsREDX PHARMA PLC·Filed 2017·Granted Dec 26, 2017·1 cites·7 claims
- 1464US2026078108A1Solid forms of a rock inhibitorREDX PHARMA PLC·Filed 2023·Application pending·0 cites
- 1559US2024279241A1Pyrido[4,3-d]pyrimidine compounds capable of inhibiting kras mutant proteinsREDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 1659US2024082244A1Pharmaceutical formulationREDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 1758US2024287078A1Quinazoline derivatives useful as ras inhibitorsREDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 1857US2024336592A1Phenyl- and pyridopyrazole derivatives as inhibitors of ddr1REDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 1956US2026069571A1Ddr1 and ddr2 inhibitors for the treatement of cancer and fibrotic diseasesREDX PHARMA PLC·Filed 2022·Application pending·0 cites
- 2052US10385065B2Antibacterial compoundsREDX PHARMA PLC·Filed 2015·Granted Aug 20, 2019·1 cites·24 claims
- 2133US2019040083A1Antibacterial compoundsREDX PHARMA PLC·Filed 2017·Application pending·0 cites
- 2232US10487093B2Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compoundsREDX PHARMA PLC·Filed 2017·Granted Nov 26, 2019·0 cites·20 claims
- 2332US2021179636A1Antibacterial compoundsREDX PHARMA PLC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REDX PHARMA PLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →